In a Bloomberg Law article, Sara Hansard references Frier Levitt’s “Pharmacy Benefit Manager Exposé: How PBMs Adversely Impact Cancer Care While Profiting at the Expense of Patients, Providers, Employers, and Taxpayers,” commissioned by COA.
This report provides a comprehensive exposé and legal analysis of the most pervasive and abusive PBM tactics, highlighting the adverse impact they have on patients, providers, and health care payers (including Medicare, Medicaid, employers, and taxpayers). It is designed as a roadmap for policymakers and regulators to better understand the opaque PBM industry as reform efforts gain steam at the federal and local levels.
To read the Bloomberg Article click here.
To read the PBM Exposé click here.
